Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broadens the scope of integrated services across the drug development lifecycle spanning discovery (chemistry, biology, drug
Approval marks Venus Remedies’ first anti-infective marketing authorization in Indonesia and enables the country’s first generic entry for this critical antibiotic combination Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the world’s leading fixed-dosage injectable manufacturers, has secured the marketing authorization from the Indonesian regulatory authority
India’s Central Drugs Standard Control Organisation (CDSCO) has released new guidelines that allow the compounding of minor drug-related violations, marking a significant step toward faster enforcement, improved compliance, and reduced litigation within the pharmaceutical ecosystem. The guidelines outline specific categories of procedural and technical lapses that
Granules India Limited today inaugurated two advanced Centres of Excellence at the Technology Research Park of IIT Hyderabad: the Ascelis Center of Excellence for Peptide Development and Characterization and the Granules Center of Excellence for Particle Engineering. The inauguration was led by Dr Krishna Prasad Chigurupati,
PNEUBEVAX 14® is Biological E. Limited’s 14-valent Pneumococcal Conjugate Vaccine · PNEUBEVAX 14® induces robust, functional serotype-specific immune response in infants to 14 serotypes, offering the broadest coverage of any paediatric Pneumococcal Conjugate Vaccine available in India Biological E. Limited (BE), a leading Hyderabad-based vaccine and pharmaceutical
Covers exclusive rights to S-pindolol, the novel therapy in development for the treatment of cachexia, in India and South Asia Represents a major step in the mission of Actimed to bring the first globally approved cancer cachexia product to patients in need Actimed Therapeutics Ltd (“Actimed”), a
Event organized by Informa Markets in India to bring over 2,000 exhibitors & 50,000 industry participants from more than 120 countries under one roof. Organized by Informa Markets in India, the 18th edition of CPHI & PMEC India 2025, South Asia's largest and most influential pharmaceutical industry event, is scheduled
The approvals strengthen India’s position as a reliable supplier of advanced pharmaceuticals across ASEAN markets where Venus Remedies already exports more than 374 products. Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), among the 10 leading fixed-dosage injectable manufacturers in the world, has secured new marketing authorizations
The evolving biosimilar regulations in the United States are poised to create new growth opportunities for Indian pharmaceutical companies, with experts predicting a significant uptick in exports and partnerships in the biopharma segment. The U.S. Food and Drug Administration’s (FDA) streamlined approval pathway for biosimilars, along
In a move to strengthen drug regulation and ensure the availability of safe, high-quality medicines, Uttar Pradesh Chief Minister Yogi Adityanath announced that the state government will double the number of drug inspectors across the state. The decision is aimed at improving the monitoring of
